Physician profile
Aliona Maxwell
NPI 1841503893
$1,934.72
in general payments reported to CMS, 2019-2025
28 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $143 · 2021: $269 · 2022: $275 · 2023: $461 · 2024: $248 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $849.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $400.42 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $156.60 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $137.26 | 2019-2020 | |
| Pfizer INC. | $135.45 | 2022-2024 | |
| Exeltis, USA INC. | $132.71 | 2019-2025 | Slynd |
| Sumitomo Pharma America, INC. | $117.21 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $115.87 | 2019-2024 | Acessa Provu System, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $110.17 | 2019-2025 | Veozah, Cresemba |
| Evofem Biosciences, INC. | $76.33 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $58.33 | 2019 | |
| Medtronic, INC. | $57.36 | 2021-2022 | |
| Sage Therapeutics, LLC | $47.91 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $44.02 | 2021-2023 | Injectafer |
| Baxter Healthcare | $37.65 | 2023 | Perclot |
| Allergan, INC. | $37.04 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $30.02 | 2019 | |
| Therapeuticsmd, INC. | $29.39 | 2019-2021 | |
| Avion Pharmaceuticals | $28.74 | 2019-2020 | |
| Coopersurgical, INC. | $25.54 | 2020-2023 | Mara Console |
| Agile Therapeutics, INC. | $23.74 | 2021-2022 | |
| Biogen, INC. | $20.70 | 2022 | |
| Organon LLC | $20.48 | 2023 | Nexplanon |
| Roche Diagnostics Corporation | $19.36 | 2021 | |
| Exact Sciences Corporation | $18.66 | 2025 | Cologuard Collection Kit |
| Lupin INC. | $14.87 | 2019 | |
| Millicent US INC | $14.55 | 2019 | |
| Mission Pharmacal Company | $12.46 | 2019 | |
| Merck Sharp & Dohme LLC | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aliona Maxwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.